Artificial Intelligence in Uveitis: Innovations in Diagnosis and Therapeutic Strategies

• Published in: Clinical ophthalmology (Auckland, N.Z.) N.Z.), 2024, Vol.18, p.3753-3766
• Main Authors: Murugan, Siva Raman Bala, Sanjay, Srinivasan, Somanath, Anjana, Mahendradas, Padmamalini, Patil, Aditya, Kaur, Kirandeep, Gurnani, Bharat
• Format: Article
• Language: English
• Subjects: Accuracy; Algorithms; Artificial intelligence; artificial intelligence (ai); Automation; Clinical decision making; Clinical outcomes; Datasets; Deep learning; deep learning (dl); Diabetes; Diabetic retinopathy; Disease; Inflammation; Language; Literature reviews; Machine learning; machine learning (ml); Macular degeneration; Medical diagnosis; Natural language processing; Neural networks; Ophthalmology; optical coherence tomography (oct); Precision medicine; Review; uveitis management
• ISSN: 1177-5467; 1177-5483
• DOI: 10.2147/OPTH.S495307

In the dynamic field of ophthalmology, artificial intelligence (AI) is emerging as a transformative tool in managing complex conditions like uveitis. Characterized by diverse inflammatory responses, uveitis presents significant diagnostic and therapeutic challenges. This systematic review explores the role of AI in advancing diagnostic precision, optimizing therapeutic approaches, and improving patient outcomes in uveitis care. A comprehensive search of PubMed, Scopus, Google Scholar, Web of Science, and Embase identified over 10,000 articles using primary and secondary keywords related to AI and uveitis. Rigorous screening based on predefined criteria reduced the pool to 52 high-quality studies, categorized into six themes: diagnostic support algorithms, screening algorithms, standardization of Uveitis Nomenclature (SUN), AI applications in management, systemic implications of AI, and limitations with future directions. AI technologies, including machine learning (ML) and deep learning (DL), demonstrated proficiency in anterior chamber inflammation detection, vitreous haze grading, and screening for conditions like ocular toxoplasmosis. Despite these advancements, challenges such as dataset quality, algorithmic transparency, and ethical concerns persist. Future research should focus on developing robust, multimodal AI systems and fostering collaboration among academia and industry to ensure equitable, ethical, and effective AI applications. The integration of AI heralds a new era in uveitis management, emphasizing precision medicine and enhanced care delivery.